OTCMTSNDF
Market cap236mUSD
Jan 03, Last price
0.70USD
1D
-0.10%
1Q
-44.94%
IPO
-52.69%
Name
Terrascend Corp
Chart & Performance
P/E
—
P/S
0.75
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
24.34%
Rev. gr., 5y
129.25%
Revenues
317m
+28.04%
Net income
-91m
L-71.62%
CFO
27m
P
Earnings
Mar 12, 2025
Profile
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 317,328 28.04% | 247,829 17.78% | ||||||
Cost of revenue | 267,639 | 252,473 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 49,689 | (4,644) | ||||||
NOPBT Margin | 15.66% | |||||||
Operating Taxes | 23,453 | 10,783 | ||||||
Tax Rate | 47.20% | |||||||
NOPAT | 26,236 | (15,427) | ||||||
Net income | (91,101) -71.62% | (320,968) -5,331.75% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 20,822 | |||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 141,011 | 50,713 | ||||||
Long-term debt | 163,755 | 224,746 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | 81,441 | 27,701 | ||||||
Net debt | 280,003 | 276,406 | ||||||
| Cash flow | ||||||||
Cash from operating activities | 27,471 | (26,123) | ||||||
CAPEX | (7,762) | (41,892) | ||||||
Cash from investing activities | (16,219) | (27,579) | ||||||
Cash from financing activities | (12,500) | 3,719 | ||||||
FCF | 17,850 | (92,168) | ||||||
| Balance | ||||||||
Cash | 24,154 | 29,753 | ||||||
Long term investments | 609 | (30,700) | ||||||
Excess cash | 8,897 | |||||||
Stockholders' equity | (928,451) | (613,801) | ||||||
Invested Capital | 1,506,333 | 1,174,419 | ||||||
ROIC | 1.96% | |||||||
ROCE | 8.27% | |||||||
| EV | ||||||||
Common stock shares outstanding | 279,286 | 244,351 | ||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 72,390 | 19,960 | ||||||
EV/EBITDA | ||||||||
Interest | 35,106 | 39,059 | ||||||
Interest/NOPBT | 70.65% | |||||||